Introduction
Experiments involving genetic deletion or pharmacological inhibition of the inducible isoform of cyclooxygenase (Cox), Cox-2 have demonstrated that this enzyme plays an important role in intestinal tumorigenesis in mouse models of familial adenomatous polyposis (FAP), such as the Apc Min/þ mouse (1-4). These models are relevant to the study of the early stages of human colorectal carcinogenesis (5) .
COX-2 is recognized as a potential human colorectal cancer (CRC) chemoprevention target (6) . However, recent clinical observations have cast doubt on the vascular safety profile of long-term systemic administration of coxib selective COX-2 inhibitors in humans (7) . An alternative CRC chemoprevention strategy that would minimize systemic toxicity is inhibition of COX-2 expression and/or activity in a cell-and tissue-specific manner, which requires detailed understanding of the mechanism(s) that regulate intestinal COX-2 expression.
Several independent studies have demonstrated that stromal cells are the predominant source of Cox-2 in mouse and human intestinal adenomas (1) (2) (8) (9) (10) (11) (12) (13) (14) (15) (16) . In addition, it has been reported that stromal cell Cox-2 expression and levels of prostaglandin (PG) E 2 (the predominant COX-derived product in intestinal mucosa) are increased in histologically normal (HN) Apc Min/þ mouse intestinal mucosa (9, 17, 18) and HN mucosa from CRC patients (18) . However, the mechanistic basis of stromal cell Cox-2 induction in intestinal adenomas and the extent of Cox-2 expression or activity in HN intestinal mucosa during different stages of intestinal tumorigenesis have not been addressed previously.
Therefore, we studied stromal cell Cox-2 expression and function in adenomas and HN intestinal mucosa at different stages of intestinal tumorigenesis in Apc Min/þ mice, in order to gain further insights into mechanisms regulating intestinal stromal cell Cox-2 expression and PGE 2 synthesis during tumour growth. intestine (SI) or colonic adenoma multiplicity in heterozygous Lys-EGFP-ki/ þ Â Apc Min/þ mice compared with C57BL/6 Â 129/Sv Apc Min/þ mice with wildtype M-lysozyme alleles (data not shown).
Measurement of intestinal permeability
Mice were acclimatized in wire-bottomed metabolic cages for 3 days with free access to food and water. Animals were fasted overnight before administration of 13.3 mg lactulose and 10.1 mg mannitol (both Sigma, Poole, UK) in 200 ml water by oral gavage. Urine produced during the 6 h test period was collected in 20 ml 20% (v/v) chlorhexidine (21) . Urinary lactulose and mannitol were measured by enzymatic methods as described (22, 23) . Data are presented as the ratio of the percentage administered dose of lactulose excreted in the urine to the percentage of the administered dose of mannitol in the same urine collection (L/M ratio).
Immunohistochemistry for Cox-2
Goat polyclonal anti-Cox-2 antibody and goat IgG control (both Santa Cruz Biotechnology, Santa Cruz, CA) were labelled with AlexaFluor 488 using a protein labelling kit (Molecular Probes, Invitrogen, Paisley, UK) according to the manufacturer's instructions. Frozen sections (5-7 mm thick) of intestine were fixed in 100% methanol at À20 C for 15 min, air dried and then rehydrated in Tris-buffered saline [0.02% (v/v)] Tween 20 (TBS-T) followed by blocking with TBS-T containing 10% (v/v) goat serum (DakoCytomation, Ely, UK) for 1 h at 20 C. Sections were then labelled for 1 h at 20 C with antiCox-2 or control antibody (1/100 dilution in TBS-T containing 10% goat serum), washed 3 times for 15 min each with TBS-T and then mounted with 4 0 , 6 diamidino-2-phenylindole (DAPI)-incorporated VectaShield (Vector Laboratories, Burlingame, CA). Labelling specificity was confirmed by preabsorption of tagged antibody with protein G-sepharose for 4 h at 20 C, prior to incubation with sections.
In situ hybridization Specific localization of Cox-2 and nitric oxide synthase 2 (Nos2) mRNA was determined by in situ hybridization using unhydrolysed riboprobes generated from linearized plasmid sense and antisense murine Cox-2 and Nos2 probe templates (Cayman Chemical, Ann Arbor, MI) using [
35 S]-UTP ($800 Ci/ mmol; Amersham Pharmacia, Amersham, UK). An antisense b-actin probe was used to test for the presence of hybridizable mRNA in the tissues studied. Sections of 4 mm were cut from paraffin-embedded blocks of intestinal tissue onto silane-treated slides under RNase-limited conditions. The methods for pre-treatment, hybridization, washing and dipping of slides in Ilford K5 for autoradiography were as described (24) . Sections were counterstained by Giemsa's method and examined under conventional or reflected light dark-field conditions using an Olympus BH2 microscope with epiillumination.
Isolation and culture of bone marrow-derived macrophages Bone marrow-derived macrophages (BMDM) were differentiated in vitro in the presence of macrophage colony-stimulating factor for 7 days as described previously (25, 26) . BMDM were stimulated for 18 h with 100 U/ml interferon (IFN)-g and 1 mg/ml lipopolysaccharide (LPS; both Sigma). Semi-quantitative RT-PCR for Cox-2 and Hypoxanthine-guanine phosphoribosyl transferase (Hprt) mRNA, as well as western blot analysis of Cox-2 and b-actin protein, was performed as described (25) .
Isolation of stromal mononuclear cells
Stromal mononuclear cells (SMNCs) were isolated from mouse SI by the method of Newberry et al. (27) , with the following modifications: the whole SI was cut into $50 pieces, which were incubated sequentially in three changes of collagenase/dispase digestion medium for 30 min at 37 C. After each incubation period, isolated SMNCs were collected by filtration through 70 mm nylon mesh (Lockertex, Warrington, UK) and maintained at 37 C in Iscove's Modified Eagle's Medium containing 10% (v/v) foetal calf serum (FCS), 1Â non-essential amino acid solution, 1 mM sodium pyruvate, 0.075% (w/v) sodium bicarbonate, 50 IU/ml penicillin, 50 mg/ml streptomycin, 0.5 mg/ml gentamicin (all from Invitrogen) and 10% (v/v) L-cell conditioned medium (26) , termed SMNC culture medium, before pooling. The total number of viable SMNCs was determined using a haemocytometer and exclusion of 0.4% (v/v) trypan blue (Sigma). C and then kept on ice in SMNC culture medium.
Cell sorting was performed on 5 Â 10 4 SMNCs using a FACS Vantage (Becton Dickinson, NJ, USA) and Cell Quest software (3000 events/s). Gates were set up to exclude PI-positive cells and cells with low forward scatter (deemed non-viable), and sort EGFP-positive cells (fluorescence level greater than that obtained by 50.1% of wild-type SMNCs) and macrophage markerpositive cells (compared with non-specific labelling with control rat IgG). Cell collection tubes were changed every 15 min and sorted cells were kept on ice until they were re-suspended in fresh SMNC culture medium.
Measurement of PGE 2 production by SMNCs
Total SMNCs and sorted cell sub-populations based on EGFP-and Mac-mixpositivity were cultured for 24 h in SMNC culture medium at 37 C in the presence of 5% CO 2 . The selective COX-2 inhibitor SC236 was a kind gift from Pharmacia, Skokie, IL [1 mM stock solution in dimethyl sulphoxide (DMSO)]. Cell-free conditioned medium was obtained and the number and the percentage viability of combined floating and adherent cells was determined using a haemocytometer and trypan blue [0.4% (v/v) in PBS] exclusion. Levels of PGE 2 were measured using a PGE 2 enzyme immunoassay (Amersham Pharmacia).
Results

Upregulation of Cox-2 in stromal cells in adenomas is not an intrinsic property of Apc
Min/þ mouse macrophages
We, and others, have previously identified the predominant Cox-2-expressing stromal cell type in Apc Min/þ mouse intestine as the macrophage (9, 18 Figure 1A and B). The presence of the Apc Min allele did not alter Cox-2 mRNA or protein levels in either un-stimulated or IFNg/LPS-stimulated BMDM ( Figure 1A and B). There was also no significant difference in PGE 2 production by un-stimulated or IFNg/LPS-stimulated Apc Min/þ BMDM compared with wild-type BMDM ( Figure 1C ). Similar findings were obtained from a comparison of Apc Min/þ and wild-type mouse peritoneal macrophages (data not shown). These data confirm that there is no significant intrinsic abnormality of Cox-2 expression by Apc Min/þ mouse macrophages and, in turn, suggest that a local stimulus may be responsible for upregulation of Cox-2 in Apc Min/þ mouse intestinal macrophages.
Stromal cell Cox-2 in intestinal tumorigenesis
Intestinal permeability is similar in Apc Min/þ mice at different stages of intestinal tumorigenesis to age-matched wild-type animals We noted that Cox-2 immunoreactivity was most intense in stromal cells located in superficial areas of Apc Min/þ mouse SI and colonic adenomas (Figure 2A and B), often just below eroded luminal epithelium. One hypothesis is that upregulation of Cox-2 in stromal macrophages, just below luminal epithelium, occurs following antigenic stimulation, secondary to increased epithelial permeability. Therefore, we measured paracellular transport of lactulose, expressed as a ratio to mannitol excretion (used as a control for variations in intestinal surface area and renal function), as a measure of SI permeability (30) . Percentage lactulose and mannitol recoveries and L/M ratio values were consistent with previous rodent SI permeability experiments ( Figure 3 ; 21,30). There was a small age-dependent increase in percentage lactulose and mannitol recovery in both wild-type and Apc Min/þ mice ( Figure 3 ). However, there was no significant difference between the L/M ratio of wild-type and Apc Min/þ mice at any age, even when adenomas are evident macroscopically. This suggests that increased permeability of epithelium in intestinal adenomas does not explain Cox-2 induction in tumour-associated superficial stromal cells.
Differential expression of Cox-2 and Nos2 in tumour stroma
If Cox-2 upregulation in tumour-associated Apc Min/þ mouse macrophages was due to activation by luminal contents, including bacterial endotoxin such as LPS, crossing 'leaky' epithelium, one might expect parallel upregulation of Cox-2 and Nos2, which characteristically occurs upon 'classical' activation of macrophages by IFNg and/or LPS in vitro (31, 32) . Therefore, we performed in situ hybridization for Cox-2 and Nos2 mRNA on adjacent sections of Apc Min/þ mouse SI adenomas in order to determine whether these two immediate early genes are co-expressed by tumour-associated macrophages in Apc Min/þ mouse neoplasms. Although Cox-2 transcripts were present in superficial stromal tissue within SI adenomas ( Figure 4A Previous studies of stromal cell Cox-2 expression in the Apc Min/þ mouse model have used immunohistochemistry alone to demonstrate Cox-2 protein localization (9, 18) . In this study, we isolated SMNCs from the SI in order to combine cell phenotype analysis by flow cytometry with quantitation of ex vivo stromal cell Cox-2 function (using PGE 2 synthesis as a 'read-out'). Newberry et al. (27) have previously demonstrated that Cox-2 levels and activity in isolated intestinal stromal cells accurately reflect mucosal Cox-2 expression and function in mouse intestine in vivo using a similar isolation technique (33) . Initially, we analysed the percentage number of Cox-2 protein-positive SMNCs in Apc Min/þ mice and wild-type littermates by immunofluorescence ( Figure 5 ). This technique demonstrated that 2.5 AE 0.8% (mean AE SEM; n ¼ 3 at age D70; viability 81.8 AE 5.0%) of freshly isolated Apc Min/þ mouse SMNCs were Cox-2-positive compared with 2.3 AE 0.9% of SMNCs from age-matched wild-type littermates (n ¼ 3; viability 81.9 AE 1.8%). Direct immunofluorescence for Cox-2 protein on frozen sections of SI and colon demonstrated that HN mucosa from both Apc Min/þ mice and wild-type contained a similar number of Cox-2-positive cells (Figure 2C and D), thus providing further evidence that our ex vivo observations on isolated cells were relevant to mucosal Cox-2 expression in vivo.
In keeping with the lack of any significant difference in the number of Cox-2 positive SMNCs between Apc Min/þ mice and wild-type littermates, there was no significant difference in Cox-2 mRNA levels (relative to Hprt mRNA levels) in freshly isolated SMNCs from D70 Apc Min/þ and wild-type mice, as measured by real time RT-PCR (data not shown). However, significant differences in ex vivo Cox-2-dependent PGE 2 synthesis by cultured SMNCs from Apc Min/þ and wild-type mice at different ages were apparent. We confirmed that the selective COX-2 inhibitor SC236 decreased PGE 2 production by wild-type D70 SMNCs in a concentration-dependent manner, with maximal inhibition (490%) occurring at a minimum concentration of 1 mM SC236, without evidence of nonspecific cell toxicity ( Figure 6A ). We then studied ex vivo PGE 2 synthesis by SMNCs from Apc Min/þ and wild-type mice at different ages in the absence or presence of 1 mM SC236 ( Figure 6B ). SMNCs from D30 mice (when only 'nascent' micro-adenomas are present) demonstrated low level PGE 2 synthesis, which was not inhibited by the selective COX-2 inhibitor SC236 implying predominant Cox-1-dependent PGE 2 production ( Figure 6B ). However, by 70 days of age (at which stage, adenomas have increased in size and are now visible macroscopically), SMNCs produced 10-30-fold higher PGE 2 levels due almost exclusively to an increase in Cox-2-dependent PGE 2 synthesis ( Figure 6B ). At D70, Apc Min/þ SMNCs produced 2-3-fold higher PGE 2 levels than 
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wild-type SMNCs (P ¼ 0.06 for the difference between Apc Min/þ and wild-type SMNCs; Mann-Whitney U Test; Figure 6B ). A methodological limitation of our studies is that we could not distinguish between isolated Apc Min/þ SMNCs originating from within adenomas and those resident in HN mucosa (the lengthy dissection required to separate adenomas from macroscopically normal SI led to a marked decrease in viability of freshly isolated SMNCs). However, comparison of PGE 2 production by D70 Apc Min/þ and wild-type SMNCs with that by D30 SMNCs suggests that SMNCs from HN mucosa (compare D30 versus D70 wild-type SMNCs), as well as from adenomas (compare Apc Min/þ versus wild-type SMNCs at D70), both contributed to increased SMNC PGE 2 synthesis in older mice when adenomas are evident macroscopically. By D110, SMNC PGE 2 synthesis had decreased in Apc 
PGE 2 synthesis by sub-populations of intestinal SMNCs
Next, we used expression of M-lysozyme and macrophagespecific cell surface markers (F4/80, ER-HR3 and MOMA-1) as tools to identify sub-populations of isolated SMNCs responsible for PGE 2 synthesis. We used mice with the enhanced green fluorescent protein (EGFP) gene inserted into the M-lysozyme locus (termed Lys-EGFP-ki mice) in order to specifically label cells of the myelomonocytic lineage, which include macrophages and neutrophil granulocytes (20, 34) . In addition, we used a mix of three antibodies (Macmix) against recognized macrophage-specific antigens (28, 29) in order to distinguish between macrophages and neutrophil granulocytes. We limited these experiments to D70 animals as PGE 2 production by total SMNCs was highest at D70 and the density of SI Mac-1-positive macrophages in Apc and Lys-EGFP-ki Â Apc þ/þ mice (n ¼ 4 each group) and viable cells that excluded PI were analysed for EGFP fluorescence and Mac-mix labelling by flow cytometry (see Figure 7 for representative flow cytometric plots). Apc þ/þ and Apc Min/þ mice generated similar numbers of viable SMNCs (Table I) (Table II) . All three other SMNC populations synthesized PGE 2 (Table II) . G þ M þ macrophages were the predominant source of PGE 2 synthesis in both Apc þ/þ and Apc Min/þ mice (Table II) . Differences in PGE 2 production were not due to variations in cell viability post-sorting (Table II) (Table II) , these Stromal cell Cox-2 in intestinal tumorigenesis differences were much smaller than those demonstrated between PGE 2 production by respective total SMNCs at D70 ( Figure 5B ). This may be explained by the prolonged duration of ex vivo handling and culture (and hence lower percentage viability) of sorted SMNCs, compared with total SMNC populations (Table II) 
Discussion
The fact that systemic selective COX-2 inhibition may not be free of significant side-effects suggests that future chemoprevention strategies, which selectively target COX-2, will need to address inhibition of COX-2 in a tissue-specific manner (36) . To this end, one approach is to abrogate COX-2 expression during carcinogenesis. As Cox-2 is predominantly localized to stromal cells at early stages of intestinal tumorigenesis (1-2,8-13), we investigated mechanisms controlling stromal cell Cox-2 expression during Apc Min/þ mouse intestinal adenoma development. Stromal macrophages also express COX-2 in human sporadic colorectal adenomas (14) (15) (16) suggesting that our studies in the Apc Min/þ mouse are likely to be of relevance to human colorectal carcinogenesis.
Having confirmed that Cox-2 expression by stromal macrophages in Apc Min/þ mouse intestinal adenomas was not a property shared by other, distinct macrophage populations (in vitro differentiated BMDM and peritoneal macrophages) in Apc
Min/þ animals, we searched for local factors that could drive stromal cell Cox-2 expression. As Cox-2 protein is predominantly localized to stromal cells just below surface epithelium, we tested whether increased intestinal permeability to luminal antigen accounted for Cox-2 expression by stromal cells in adenomas. We did not demonstrate any significant difference in permeability to lactulose between Apc Min/þ and wild-type mice at different stages of intestinal tumorigenesis, from a stage when micro-adenomata only are present (D30) to a situation in which macroscopic adenomas are noted along the length of the intestine (D140). We can not rule out small, localized changes in epithelial integrity in adenomas on the basis of this test of global intestinal permeability. However, the fact that Cox-2-expressing stromal cells in intestinal adenomas did not co-express Nos2 mRNA is also consistent with the absence of any change in epithelial permeability to luminal antigen, leading to 'classical' macrophage activation.
Recently, the concept of phenotypic heterogeneity of macrophages has strengthened with classification of M1 ('classically' activated) and M2 (or alternatively activated) macrophages as extremes of a continuum of phenotypic and functional states of these cells (37) . Tumour-associated macrophages are often polarized to the M2 phenotype, a key feature of which is absence of Nos2 expression (38) . It will be interesting to study other markers of the M2 phenotype (e.g. arginase) in Cox-2-expressing stromal macrophages in Apc Min/ þ mouse adenomas in order to define the predominant macrophage phenotype in these tumours. This is important as different cytokines (representing potential chemoprevention targets) drive M2, as opposed to M1, polarization e.g. interleukin (IL)-10, IL-4 and IL-13 (37, 38) .
We have demonstrated that viable SMNCs can be isolated from Apc Min/þ animals and that phenotypically distinct subpopulations of SMNCs can be sorted for further in vitro studies. An important component of future studies will be improvement in overall SMNC viability, which will allow more refined ex vivo experimentation. We used Lys-EGFP-ki mice as a tool for investigation of myelomonocytic cells in the SI lamina propria, for the first time. Simultaneous labelling with a cocktail of antibodies to macrophage-specific epitopes (designed to maximize detection of phenotypically heterogeneous macrophage sub-populations) demonstrated that M-lysozyme is expressed by the majority of SI lamina propria macrophages and that neutrophils make a significant contribution to M-lysozyme expression in mouse SI. Previously, lysozyme mRNA was not detected in resident macrophages in mouse SI by in situ hybridization using a [
35 S]-labelled anti-sense lysozyme riboprobe (39) . However, it is likely that this in situ hybridization technique was not sufficiently sensitive to detect relatively low level expression of Mlysozyme transcripts. Experiments with sorted SMNCs suggested that several cell types contribute to PGE 2 production including G þ M þ macrophages and G þ M À neutrophils. The relative contribution of Cox-1 and Cox-2 to PGE 2 production appears to vary depending on the cellular source of PGE 2 in the SI with Cox-2 being the predominant isoform responsible for PGE 2 synthesis in G þ M þ macrophages. There was a significant increase in Cox-2-dependent PGE 2 synthesis by isolated SMNCs from both Apc Min/þ and wildtype mice between D30 and D70. This may be related to changes in diet and/or luminal flora in the post-weaning period. At D70, Cox-2-dependent PGE 2 synthesis by isolated SMNCs was higher in Apc Min/þ mice compared with wildtype littermates, despite little difference in Cox-2 mRNA or protein levels. This is consistent with previous data demonstrating a higher PGE 2 content of histologically normal SI of Apc Min/þ mice compared with wild-type SI (17) . Our data imply that another rate-limiting step for PGE 2 synthesis also controls PGE 2 synthesis in Apc Min/þ mice, perhaps involving Cox substrate (arachidonic acid) availability by phospholipases and/or generation of PGE 2 by PGE synthases (40, 41) . To date, the role of different phospholipase A 2 and PGE synthase isoforms in PGE 2 synthesis by SMNCs and their role in intestinal tumorigenesis has received little attention compared with COX-2 (40-43), despite the fact that they represent potential targets for novel immunomodulatory and cancer chemoprevention therapy.
Consistent with our data showing decreased PGE 2 synthesis by isolated SMNCs from Apc Min/þ and wild-type mice between D70 and D110, Kettunen et al. (35) have demonstrated that PGE 2 levels in the luminal content of the distal SI of Apc Min/þ and wild-type mice decrease by 30-50% between 56 and 105 days of age. We consistently measured PGE 2 synthesis by the same number of SMNCs from Apc Min/þ and wild-type mice at each age. Therefore, selective depletion of Cox-2-expressing cells from the SI lamina propria of Apc Min/þ mice by D110 could explain the overall decrease in PGE 2 production by SMNCs despite ongoing growth of intestinal tumours containing Cox-2-positive stromal cells. Apc Min/þ mice exhibit haematopoietic abnormalities, including peripheral lymphodepletion, from approximately day 80 onwards (44) , which might impact on a specific population of PGE 2 -synthesizing cells in the intestinal mucosa. The peak in PGE 2 synthesis by SMNCs at D70, at a time of active tumour growth in Apc Min/þ mice, suggests that there may be an optimal period for targeting PGE 2 synthesis and/or downstream PGE 2 signalling during intestinal tumorigenesis.
In conclusion, we have addressed the novel concept of cellspecific inhibition of Cox-2 as a chemoprevention strategy by investigating the regulation of stromal Cox-2 expression during intestinal tumorigenesis in the Apc Min/þ mouse. Simple
Stromal cell Cox-2 in intestinal tumorigenesis antigenic stimulation of stromal macrophages is unlikely to explain stromal cell Cox-2 expression in adenomas or the changes in PGE 2 synthesis by isolated SMNCs at different stages of tumorigenesis. Further work is now required to define the precise mechanistic basis of stromal cell Cox-2 induction and changes in PGE 2 synthesis during tumorigenesis.
